Literature DB >> 21481040

Towards responsible cord blood banking models.

P Rebulla1, L Lecchi.   

Abstract

On 31 May 2010, 14 072 567 bone marrow/apheresis donors registered in 44 countries and 426 501 cord blood units banked in 26 countries for public use were available to treat candidates to haemopoietic stem cell transplant lacking a family related compatible donor. Despite these impressive numbers, additional efforts are required to ensure that all patients, including those from ethnic minorities, can promptly find a suitable donor. Governments, clinicians, scientists, patients and stakeholders should share the responsibility to develop haemopoietic stem cell donation and cord blood banking models able to fully match all patient needs. In this regard, current scientific evidence and prevalent opinions among expert clinicians support solidaristic cord blood donation for public use against the alternative option of commercial autologous cord blood storage.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21481040      PMCID: PMC6496645          DOI: 10.1111/j.1365-2184.2010.00720.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  18 in total

Review 1.  Double umbilical cord blood transplant: more than a cell dose?

Authors:  Anfisa Stanevsky; Avichai Shimoni; Ronit Yerushalmi; Arnon Nagler
Journal:  Leuk Lymphoma       Date:  2010-06

2.  Public-private partnership in cord blood banking.

Authors:  Nicholas M Fisk; Rifat Atun
Journal:  BMJ       Date:  2008-03-22

Review 3.  Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine.

Authors:  Darren Lau; Ubaka Ogbogu; Benjamin Taylor; Tania Stafinski; Devidas Menon; Timothy Caulfield
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

Review 4.  Banking on cord blood stem cells.

Authors:  Michael J Sullivan
Journal:  Nat Rev Cancer       Date:  2008-06-12       Impact factor: 60.716

5.  Successful first-line treatment with double umbilical cord blood transplantation in severe aplastic anemia.

Authors:  H J Kang; J W Lee; H Kim; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2009-09-28       Impact factor: 5.483

Review 6.  Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.

Authors:  Colleen Delaney; Jonathan A Gutman; Frederick R Appelbaum
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

7.  Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).

Authors:  Mahmoud Aljurf; Syed Z Zaidi; Fazal Hussain; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Mohamad Jahani; Hossam Kamel Mahmoud; Ala'a Haddad; Salman Adil; Tarek Ben Othman; Mahmoud M Sarhan; David Dennison; Ahmad Ibrahim; Said Benchekroun; Mouhab Ayas; Hazzaa Al Zahrani; Fahad Al Mohareb; Hassan El Solh
Journal:  Transfus Apher Sci       Date:  2010-01-27       Impact factor: 1.764

8.  Should double cord blood transplants be the preferred choice when a sibling donor is unavailable?

Authors:  John E Wagner
Journal:  Best Pract Res Clin Haematol       Date:  2009-12       Impact factor: 3.020

9.  Cost-effectiveness of private umbilical cord blood banking.

Authors:  Anjali J Kaimal; Catherine C Smith; Russell K Laros; Aaron B Caughey; Yvonne W Cheng
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

10.  Costs of pediatric allogeneic hematopoietic-cell transplantation.

Authors:  Navneet S Majhail; Jaya M Mothukuri; Margaret L Macmillan; Michael R Verneris; Paul J Orchard; John E Wagner; Daniel J Weisdorf
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

View more
  1 in total

Review 1.  A comparative analysis of the opinions from European national and international ethics committees regarding the collection, storage and use of umbilical cord blood.

Authors:  Carlo Petrini
Journal:  Blood Transfus       Date:  2012-02-13       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.